Biologically-active xanthine derivatives

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530/5.04, 260/24

C07K 5/06 (2006.01) A61K 31/52 (2006.01) A61K 38/05 (2006.01) C07D 473/04 (2006.01) C07D 473/06 (2006.01) C07D 473/08 (2006.01) C07D 519/00 (2006.01) C07K 5/065 (2006.01) A61K 38/00 (2006.01)

Patent

CA 1271597

ABSTRACT OF THE DISCLOSURE Certain functionalized congeners of 1,3- dialkylxanthine exhibit high potency and selectivity as antagonists for A1- and A2-adenosine receptors and are suitable for attachment to probes, drug carriers, or solid supports. These derivatives are characterized by the presence of a phenyl at the 8 position para- substitued with a functionalized chain to provide high water solubility and high receptor affinity. Some of these analogs, containing a distal amino- or carboxylic- functionalized chain, are suitable for synthesis of amino acid conjugates. The compounds of this invention are suitable for use as antiallergenic, antiasthmatic, or cardiotonic drugs, central nervous system stimulants, and diuretics.

493865

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Biologically-active xanthine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biologically-active xanthine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically-active xanthine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1298448

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.